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The two fused ﬁve- and six-membered rings in the molecule of
the title compound, C8H6BrN3O2,are approximately coplanar,
the largest deviation from the mean plane being 0.011 (3) A ˚ at
the NH atom. The acetyl group is slightly twisted with respect
to the imidazo[4,5-b]pyridine system, making a dihedral angle
of 2.7 (2) . In the crystal, adjacent molecules are linked by
intermolecular N—H   N and C—H   O hydrogen bonds,
forming inﬁnite chains.
Related literature
For background information on the pharmacological activities
of imidazo[4,5-b]pyridines, see: Kale et al. (2009); Silverman
(2004); Cristalli et al. (1995); Cundy et al. (1997); Banie et al.
(2007); Mader (2008); Janssens et al. (1985); Bavetsias et al.
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Table 1
Hydrogen-bond geometry (A ˚ ,  ).
D—H   AD —H H   AD    AD —H   A
N2—H2   N1
i 0.86 2.02 2.877 (3) 175
C3—H3   O2
ii 0.93 2.56 3.481 (3) 172
Symmetry codes: (i)  x   1; y þ 2; z þ 2; (ii)  x þ 1; y þ 1; z þ 2.
Data collection: APEX2 (Bruker, 2009); cell reﬁnement: SAINT
(Bruker, 2009); data reduction: SAINT; program(s) used to solve
structure: SHELXS97 (Sheldrick, 2008); program(s) used to reﬁne
structure: SHELXL97 (Sheldrick, 2008); molecular graphics:
ORTEPIII (Burnett & Johnson, 1996) and ORTEP-3 for Windows
(Farrugia, 1997); software used to prepare material for publication:
SHELXL97.
Supplementary data and ﬁgures for this paper are available from the
IUCr electronic archives (Reference: DN2682).
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1-Acetyl-6-bromo-1H-imidazo[4,5-b]pyridin-2(3H)-one
S. Dahmani, Y. Kandri Rodi, S. V. Luis, E. M. Essassi and L. El Ammari
Comment
Imidazo[4,5-b]pyridines represent the major backbone of numerous medical and biochemical agents possessing different
chemical and pharmacological features (Kale et al., 2009; Silverman, 2004), which impart them diverse biological properties
like antiviral (Cristalli et al.,1995; Cundy et al., 1997; Banie et al., 2007), and anti-inflammatory (Mader, 2008) activity.
Substituted imidazo[4,5-b]pyridines have also been tested for their potential selective antihistamine (H1) agents (Janssens
et al.,1985). Imidazo[4,5-b]pyridine derivatives were also reported as Aurora kinases (Bavetsias et al., 2007) and cyclic
PDE inhibitors (Coates et al.,1993). Importantly,imidazo[4,5-b]pyridine is a structural analogue of purine whose derivatives
easily interact with large biomolecules such as DNA, RNA or diverse proteins in vivo.
The molecular plot of the crystal structure of 3-Acetyl-6-bromo-1,3-dihydro- imidazo[4,5-b]pyridin-2-one is shown in
Fig.1. The two fused five and six-membered rings building the molecule are nearly planar with the maximum deviation
from the mean plane being -0.011 (3) A ° at N2. They form a dihedral angle of 2.7 (2)° with the acetyl group. In the crystal,
adjacent molecules are linked by intermolecular N—H···N and C—H···O hydrogen bonding in the way to form infinite
chains as shown in Fig. 2 and Table 1.
Experimental
To a stirred solution of 6-bromo-1,3-dihydro-imidazo[4,5 - b-]pyridin-2-one (0.2 g; 93.4 mmol), K2CO3 (0.38 g; 2.8 mmol),
and tetra n-butyl ammonium bromide (0.03 g; 9.34 10–5 mol) in DMF, acetyl chloride (0.08 ml; 1.12 mmol) was added
dropwise. The mixture was heated under reflux for 24 h. After completion of reaction (monitored by TLC), the salt was
filtered and the solvent was removed under reduced pressure. The resulting residue was purified by column chromatography
on silica gel using (ethylacetate/hexane) (1/1) as eluent. Crystals were isolated after the solvent was allowed to evaporate.
Refinement
H atoms were located in a difference map and treated as riding with C—H = 0.93 Å for all aromatic H atoms and 0.96 Å
for the methyl with Uiso(H) = 1.2 Ueq and Uiso(H) = 1.5 Ueq for the aromatic and methyl respectively.
Figures
Fig. 1. : Molecular view of the title compound with the atom-labelling scheme. Displacement
ellipsoids are drawn at the 50% probability level. H atoms are represented as small circles of
arbitrary radii.supplementary materials
sup-2
Fig. 2. : Partial packing view showing the N-H···N and C-H···O hydrogen bonds as dashed
lines. H atoms not involved in hydrogen bonding have been omitted for clarity. [Symmetry
codes: (i) -x-1, -y+2, -z+2; (ii) -x+1, -y+1, -z+2].
1-Acetyl-6-bromo-1H-imidazo[4,5-b]pyridin-2(3H)-one
Crystal data
C8H6BrN3O2 Z = 2
Mr = 256.07 F(000) = 252
Triclinic, P1 Dx = 1.887 Mg m−3
Hall symbol: -P 1 Melting point: 507 K
a = 4.8302 (15) Å Mo Kα radiation, λ = 0.71073 Å
b = 9.645 (3) Å Cell parameters from 1685 reflections
c = 9.809 (3) Å θ = 2.1–26.0°
α = 81.542 (7)° µ = 4.53 mm−1
β = 85.735 (7)° T = 298 K
γ = 89.676 (8)° Fiber, colourless
V = 450.8 (2) Å3 0.41 × 0.16 × 0.11 mm
Data collection
Bruker APEXII CCD
diffractometer 1685 independent reflections
Radiation source: fine-focus sealed tube 1583 reflections with I > 2σ(I)
graphite Rint = 0.019
φ and ω scans θmax = 26.0°, θmin = 2.1°
Absorption correction: multi-scan
(SADABS; Bruker, 2009) h = −5→5
Tmin = 0.423, Tmax = 0.607 k = −11→11
2559 measured reflections l = 0→12
Refinement
Refinement on F2 Primary atom site location: structure-invariant direct
methods
Least-squares matrix: full Secondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.028
Hydrogen site location: inferred from neighbouring
sites
wR(F2) = 0.074 H-atom parameters constrained
S = 1.07
w = 1/[σ2(Fo
2) + (0.0374P)2 + 0.2048P]
where P = (Fo
2 + 2Fc
2)/3
1685 reflections (Δ/σ)max = 0.001
128 parameters Δρmax = 0.43 e Å−3supplementary materials
sup-3
0 restraints Δρmin = −0.48 e Å−3
Special details
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The
cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds
in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used
for estimating esds involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional
R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > 2σ(F2) is used only for calculating R-
factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large
as those based on F, and R- factors based on ALL data will be even larger.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)
x y z Uiso*/Ueq
C1 −0.0666 (6) 0.9228 (3) 0.7492 (3) 0.0412 (6)
H1 −0.0912 0.9789 0.6654 0.049*
C2 0.1373 (5) 0.8216 (3) 0.7536 (2) 0.0371 (5)
C3 0.1881 (5) 0.7340 (3) 0.8759 (2) 0.0377 (5)
H3 0.3253 0.6658 0.8796 0.045*
C4 0.0199 (5) 0.7562 (3) 0.9904 (2) 0.0355 (5)
C5 −0.1838 (5) 0.8602 (3) 0.9766 (3) 0.0372 (5)
C6 −0.2202 (6) 0.7636 (3) 1.2009 (3) 0.0435 (6)
C7 0.1715 (7) 0.5870 (3) 1.1871 (3) 0.0466 (6)
C8 0.1168 (8) 0.5301 (3) 1.3357 (3) 0.0588 (8)
H8A 0.2348 0.4510 1.3590 0.088*
H8B −0.0740 0.5012 1.3534 0.088*
H8C 0.1541 0.6013 1.3909 0.088*
N1 −0.2322 (5) 0.9436 (2) 0.8618 (2) 0.0426 (5)
N2 −0.3244 (5) 0.8613 (3) 1.1034 (2) 0.0435 (5)
H2 −0.4601 0.9164 1.1191 0.052*
N3 −0.0003 (5) 0.6957 (2) 1.1302 (2) 0.0395 (5)
O1 −0.2966 (5) 0.7398 (2) 1.3223 (2) 0.0595 (6)
O2 0.3528 (6) 0.5462 (3) 1.1138 (2) 0.0757 (8)
Br1 0.35286 (6) 0.80290 (3) 0.58804 (2) 0.04632 (13)
Atomic displacement parameters (Å2)
U11 U22 U33 U12 U13 U23
C1 0.0412 (14) 0.0477 (14) 0.0338 (13) 0.0047 (11) −0.0012 (10) −0.0033 (10)
C2 0.0392 (14) 0.0439 (13) 0.0276 (11) −0.0007 (10) 0.0057 (10) −0.0072 (9)
C3 0.0387 (14) 0.0428 (12) 0.0310 (12) 0.0059 (10) 0.0035 (10) −0.0064 (10)
C4 0.0369 (13) 0.0405 (12) 0.0283 (11) 0.0025 (10) 0.0032 (9) −0.0050 (9)
C5 0.0330 (13) 0.0449 (13) 0.0341 (12) 0.0037 (10) 0.0031 (10) −0.0100 (10)
C6 0.0405 (15) 0.0523 (15) 0.0366 (14) 0.0057 (11) 0.0085 (11) −0.0088 (11)
C7 0.0598 (18) 0.0451 (14) 0.0325 (13) 0.0098 (12) 0.0069 (12) −0.0034 (10)supplementary materials
sup-4
C8 0.078 (2) 0.0572 (17) 0.0349 (15) 0.0131 (15) 0.0123 (14) 0.0039 (12)
N1 0.0397 (13) 0.0504 (12) 0.0371 (12) 0.0090 (10) −0.0002 (9) −0.0059 (9)
N2 0.0382 (12) 0.0550 (13) 0.0359 (12) 0.0105 (10) 0.0076 (9) −0.0074 (9)
N3 0.0417 (12) 0.0461 (11) 0.0287 (10) 0.0075 (9) 0.0083 (8) −0.0045 (8)
O1 0.0640 (14) 0.0745 (14) 0.0354 (11) 0.0152 (11) 0.0188 (9) −0.0049 (9)
O2 0.0976 (19) 0.0822 (16) 0.0386 (11) 0.0532 (15) 0.0185 (11) 0.0060 (10)
Br1 0.0522 (2) 0.0565 (2) 0.02805 (16) 0.00477 (12) 0.00836 (11) −0.00472 (11)
Geometric parameters (Å, °)
C1—N1 1.354 (3) C6—O1 1.209 (3)
C1—C2 1.381 (4) C6—N2 1.363 (4)
C1—H1 0.9300 C6—N3 1.433 (3)
C2—C3 1.398 (4) C7—O2 1.193 (4)
C2—Br1 1.894 (2) C7—N3 1.409 (4)
C3—C4 1.379 (3) C7—C8 1.486 (4)
C3—H3 0.9300 C8—H8A 0.9600
C4—C5 1.401 (4) C8—H8B 0.9600
C4—N3 1.406 (3) C8—H8C 0.9600
C5—N1 1.319 (3) N2—H2 0.8600
C5—N2 1.374 (3)
N1—C1—C2 122.6 (2) N2—C6—N3 105.9 (2)
N1—C1—H1 118.7 O2—C7—N3 118.5 (2)
C2—C1—H1 118.7 O2—C7—C8 123.7 (3)
C1—C2—C3 122.0 (2) N3—C7—C8 117.8 (2)
C1—C2—Br1 118.30 (19) C7—C8—H8A 109.5
C3—C2—Br1 119.66 (19) C7—C8—H8B 109.5
C4—C3—C2 115.1 (2) H8A—C8—H8B 109.5
C4—C3—H3 122.5 C7—C8—H8C 109.5
C2—C3—H3 122.5 H8A—C8—H8C 109.5
C3—C4—C5 119.2 (2) H8B—C8—H8C 109.5
C3—C4—N3 134.3 (2) C5—N1—C1 115.0 (2)
C5—C4—N3 106.5 (2) C6—N2—C5 110.9 (2)
N1—C5—N2 125.6 (2) C6—N2—H2 124.6
N1—C5—C4 126.0 (2) C5—N2—H2 124.6
N2—C5—C4 108.4 (2) C4—N3—C7 124.2 (2)
O1—C6—N2 127.0 (3) C4—N3—C6 108.4 (2)
O1—C6—N3 127.1 (3) C7—N3—C6 127.4 (2)
N1—C1—C2—C3 −0.5 (5) N1—C5—N2—C6 −178.9 (3)
N1—C1—C2—Br1 179.6 (2) C4—C5—N2—C6 0.7 (3)
C1—C2—C3—C4 0.1 (4) C3—C4—N3—C7 0.3 (5)
Br1—C2—C3—C4 −179.98 (19) C5—C4—N3—C7 −179.4 (3)
C2—C3—C4—C5 0.5 (4) C3—C4—N3—C6 −179.8 (3)
C2—C3—C4—N3 −179.2 (3) C5—C4—N3—C6 0.5 (3)
C3—C4—C5—N1 −0.8 (4) O2—C7—N3—C4 2.8 (5)
N3—C4—C5—N1 178.9 (3) C8—C7—N3—C4 −177.5 (3)
C3—C4—C5—N2 179.5 (2) O2—C7—N3—C6 −177.1 (3)
N3—C4—C5—N2 −0.7 (3) C8—C7—N3—C6 2.6 (5)
N2—C5—N1—C1 −179.9 (3) O1—C6—N3—C4 −179.6 (3)supplementary materials
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C4—C5—N1—C1 0.5 (4) N2—C6—N3—C4 0.0 (3)
C2—C1—N1—C5 0.2 (4) O1—C6—N3—C7 0.3 (5)
O1—C6—N2—C5 179.1 (3) N2—C6—N3—C7 179.8 (3)
N3—C6—N2—C5 −0.4 (3)
Hydrogen-bond geometry (Å, °)
D—H···A D—H H···A D···A D—H···A
N2—H2···N1i 0.86 2.02 2.877 (3) 175.
C3—H3···O2ii 0.93 2.56 3.481 (3) 172.
Symmetry codes: (i) −x−1, −y+2, −z+2; (ii) −x+1, −y+1, −z+2.supplementary materials
sup-6
Fig. 1supplementary materials
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Fig. 2